Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
European Urology Oncology
|
November 3, 2019
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
Denis Maillet, Nathalie Allioli, Julien Peron, et al.
Cancer Medicine
|
August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer
Cedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
Gynecologic Oncology
|
October 26, 2013
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network
Denis Maillet, Thibaut Goulvent, Ruth Rimokh, et al.
The French Journal of Urology
|
June 1, 2024
Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study)
Carole Helissey, Denis Maillet, Bérengère Narciso, et al.
Bulletin Du Cancer
|
September 5, 2024
[Metastatic castration-resistant prostate cancer and PARP inhibitors: From tumor genomics to new therapeutic combinations]
Stéphane Oudard, Marc-Olivier Timsit, Denis Maillet, et al.
Histopathology
|
June 3, 2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study
Thibault Goulvent, Isabelle Ray-Coquard, Stéphane Borel, et al.
Clinical Genitourinary Cancer
|
December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA Study
Thibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
The French Journal of Urology
|
October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion
Delphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Nature Reviews. Urology
|
May 17, 2018
Systemic treatments for high-risk localized prostate cancer
Géraldine Pignot, Denis Maillet, Emmanuel Gross, et al.
Cancers
|
June 2, 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
European Urology Oncology
|
November 3, 2019
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
Denis Maillet, Nathalie Allioli, Julien Peron, et al.
Cancer Medicine
|
August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer
Cedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
Gynecologic Oncology
|
October 26, 2013
Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network
Denis Maillet, Thibaut Goulvent, Ruth Rimokh, et al.
The French Journal of Urology
|
June 1, 2024
Multidisciplinary real-world management of metastatic castration-sensitive prostate cancer: A French national study (PROFILE study)
Carole Helissey, Denis Maillet, Bérengère Narciso, et al.
Bulletin Du Cancer
|
September 5, 2024
[Metastatic castration-resistant prostate cancer and PARP inhibitors: From tumor genomics to new therapeutic combinations]
Stéphane Oudard, Marc-Olivier Timsit, Denis Maillet, et al.
Histopathology
|
June 3, 2015
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study
Thibault Goulvent, Isabelle Ray-Coquard, Stéphane Borel, et al.
Clinical Genitourinary Cancer
|
December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA Study
Thibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
The French Journal of Urology
|
October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinion
Delphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Nature Reviews. Urology
|
May 17, 2018
Systemic treatments for high-risk localized prostate cancer
Géraldine Pignot, Denis Maillet, Emmanuel Gross, et al.
Cancers
|
June 2, 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes
Charline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, et al.
Page
of 7